ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1957

Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study

Aïcha Kante1, Andreea Afana2, Damien Sène3, Valérie Bousson4, Trecy Goncalves5, Edouard Ballout5, Solenn Toupin5, Jean-Guillaume Dillinger6, William Bigot3, Valentin Pagis7, Karine Champion3, Ruxandra burlacu7, stephane mouly3, Patrick Henry6, Theo Pezel6 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 5Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 6Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 7Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Heart disease, Magnetic resonance imaging (MRI), prevention, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease marked by inflammation, microvascular changes and fibrosis. Cardiac comorbidities are the leading cause of mortality. Early diagnosis of cardiovascular dysfunction remains difficult prior to clinical manifestations. Cardiac MRI (CMR) has emerged as a great noninvasive tool to assess cardiological impact in SSc. Hemodynamic forces (HDF) are a measurement of the global force exchanged between blood volume and myocardium assessed using CMR, based on the Navier-Stokes equation. In this study, we aim to assess diagnostic value of HDF measurement in SSc compared to healthy controls (HC), as a potential early indicator of subclinical cardiac dysfunction.  

Methods: In a single-center study, patients with SSc who met the American college of rheumatology and European League against Rheumatism classification criteria were included and a 1.5T CMR exam was performed. HDF were obtained using an advanced post-processing software (Medis Suite, Leiden, Netherlands). Movements from deformation imaging of 2, 3, and 4-chamber cine were used for longitudinal (apical-basal – Figure 1) and transversal (septal‐lateral) left ventricle (LV) HDF calculation. To compare different LV sizes, HDF were normalized, thus reported as percentage of gravity acceleration.

Results: Of the 11 SSc patients (age 46.27±15.2 years, 19% male) recruited, 5 (46%) patients had a diffuse form and 5 (46%) patients had pulmonary hypertension. Two (18%) patients  LV systolic dysfunction with a mean LV ejection fraction (LVEF) of 59%. Five patients (46%) patients had right ventricle (RV) systolic dysfunction with a mean RVEF of 50%. We compared HDF in 11 SSc patients and in 11 age-matched healthy controls from an external cohort. SSc patients showed larger LV longitudinal HDF in systole (both RMS and peak, p=0.029, respectively p=0.047), changes which could be explained by anatomical deformation caused by increased pressure in the RV. Diastolic deceleration was significantly lower in SSc (p=0.040), a finding that might indicate reduced LV compliance in the context of elevated LV filling pressures. Furthermore, the transverse to longitudinal ratio and the angle – elevated as compensatory mechanisms – were strongly correlated with the Rodnan score, a well-known predictor for disease severity and prognosis. 

Conclusion: HDF analysis has the potential to be a more sensitive marker of cardiac deterioration in SSc patients compared to traditional volumetric and functional parameters. 

Supporting image 1

Figure 1. Cardiac magnetic resonance findings in systemic sclerosis patients.
A – Circular pericardial effusion;
B – Severe right ventricular (RV) dilatation;
C – Dilatation of both atria;
D – Septal flattening (D-shaped left ventricle) as a sign of pulmonary arterial hypertension;
E – Late gadolinium enhancement (arrows) of right ventricular insertion point;
F – Myocardial infarction scar (arrows) in the anterior, lateral and inferior walls of left ventricle;
G – Diffuse myocardial fibrosis;
H – Myocardial edema;
I – Decreased global longitudinal strain in the RV myocardium.

Supporting image 2

Figure 2. Longitudinal (apical-basal) left ventricular hemodynamic force profile across the cardiac cycle, illustrating key intracardiac events during distinct time intervals.
 

Supporting image 3

Figure. A, C, E, G: Representation of the apical-base (longitudinal – red curve) and lateral- septal (transversal – blue curve) hemodynamic forces (HDF) in the left ventricle in a systemic sclerosis patient;
B, D, F, H: The polar histogram, projected on the left ventricle, shows the magnitude and direction of HDF;
A, B – HDF throughout the complete cardiac cycle;
C, D – HDF throughout the systole;
E, F – HDF throughout the systolic propulsive phase;
G, H – HDF throughout the systolic-diastolic transition.


Disclosures: A. Kante: None; A. Afana: None; D. Sène: None; V. Bousson: None; T. Goncalves: None; E. Ballout: None; S. Toupin: None; J. Dillinger: None; W. Bigot: None; V. Pagis: None; K. Champion: None; R. burlacu: None; s. mouly: None; P. Henry: None; T. Pezel: None; C. Comarmond: None.

To cite this abstract in AMA style:

Kante A, Afana A, Sène D, Bousson V, Goncalves T, Ballout E, Toupin S, Dillinger J, Bigot W, Pagis V, Champion K, burlacu R, mouly s, Henry P, Pezel T, Comarmond C. Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessing-left-ventricular-hemodynamic-forces-in-systemic-sclerosis-patients-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-left-ventricular-hemodynamic-forces-in-systemic-sclerosis-patients-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology